AR006520A1 - Derivados de 2-arilpirazolisoquinolina y cinolinona y procedimiento para su preparacion. - Google Patents

Derivados de 2-arilpirazolisoquinolina y cinolinona y procedimiento para su preparacion.

Info

Publication number
AR006520A1
AR006520A1 ARP970101094A ARP970101094A AR006520A1 AR 006520 A1 AR006520 A1 AR 006520A1 AR P970101094 A ARP970101094 A AR P970101094A AR P970101094 A ARP970101094 A AR P970101094A AR 006520 A1 AR006520 A1 AR 006520A1
Authority
AR
Argentina
Prior art keywords
alkyl
phenyl
bond
optionally substituted
alkoxy
Prior art date
Application number
ARP970101094A
Other languages
English (en)
Spanish (es)
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605803.7A external-priority patent/GB9605803D0/en
Priority claimed from GBGB9610474.0A external-priority patent/GB9610474D0/en
Priority claimed from GBGB9610894.9A external-priority patent/GB9610894D0/en
Priority claimed from GBGB9700862.7A external-priority patent/GB9700862D0/en
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of AR006520A1 publication Critical patent/AR006520A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP970101094A 1996-03-20 1997-03-19 Derivados de 2-arilpirazolisoquinolina y cinolinona y procedimiento para su preparacion. AR006520A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9605803.7A GB9605803D0 (en) 1996-03-20 1996-03-20 Pharmaceutically-active compound
GBGB9610474.0A GB9610474D0 (en) 1996-05-18 1996-05-18 Pharmaceutically active compounds
GBGB9610894.9A GB9610894D0 (en) 1996-05-24 1996-05-24 Pharmaceutically useful compounds
GBGB9700862.7A GB9700862D0 (en) 1997-01-16 1997-01-16 Pharmaceutically useful compounds

Publications (1)

Publication Number Publication Date
AR006520A1 true AR006520A1 (es) 1999-09-08

Family

ID=27451427

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970101094A AR006520A1 (es) 1996-03-20 1997-03-19 Derivados de 2-arilpirazolisoquinolina y cinolinona y procedimiento para su preparacion.

Country Status (19)

Country Link
EP (1) EP0888347A1 (cs)
JP (1) JP2000506884A (cs)
KR (1) KR20000064716A (cs)
CN (1) CN1218472A (cs)
AR (1) AR006520A1 (cs)
AU (1) AU712141B2 (cs)
BR (1) BR9708103A (cs)
CA (1) CA2247814A1 (cs)
CZ (1) CZ297798A3 (cs)
EE (1) EE9800298A (cs)
ID (1) ID16283A (cs)
IL (1) IL126271A0 (cs)
IS (1) IS4848A (cs)
NO (1) NO984290L (cs)
NZ (1) NZ331614A (cs)
PL (1) PL328921A1 (cs)
SK (1) SK118798A3 (cs)
TR (1) TR199801861T2 (cs)
WO (1) WO1997034893A1 (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110749A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Substituierte Aminodicarbonsäurederivate
JP2003002863A (ja) * 2001-06-25 2003-01-08 Nippon Soda Co Ltd 安息香酸類の製造方法および新規化合物
SE0102404D0 (sv) * 2001-07-04 2001-07-04 Active Biotech Ab Novel immunomodulating compounds
US6642249B2 (en) 2001-07-04 2003-11-04 Active Biotech Ab Immunomodulating compounds
DE10229762A1 (de) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase
CA2506524A1 (en) * 2002-11-22 2004-06-10 Active Biotech Ab Pyrazoloquinolines with immunomodulating activity
EP1572689B1 (en) * 2002-12-16 2009-03-11 Active Biotech AB Tetracyclic immunomodulatory compounds
PL383655A1 (pl) * 2003-03-14 2008-04-14 Medigene Limited Związki heterocykliczne regulujące układ odpornościowy
GB0325644D0 (en) 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
SV2005001973A (es) 2003-12-12 2005-11-04 Wyeth Corp Quinolinas utiles en el tratamiento de enfermedades cardiovasculares ref. wyth0090-504 (am101500)
FR2870239B1 (fr) * 2004-05-11 2006-06-16 Sanofi Synthelabo Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique.
GB0411770D0 (en) * 2004-05-26 2004-06-30 Avidex Ltd Immuno inhibitory heterocyclic compouds
CA2576256C (en) 2004-08-09 2012-01-03 Avidex Limited Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors
KR101107800B1 (ko) 2006-10-31 2012-01-25 화이자 프로덕츠 인코포레이티드 무기질코르티코이드 수용체 길항제로서의 피라졸린 화합물
CN102372710A (zh) * 2010-08-18 2012-03-14 山东轩竹医药科技有限公司 作为盐皮质激素受体拮抗剂的并环类化合物
US20130338367A1 (en) 2011-02-09 2013-12-19 Nissan Chemical Industries, Ltd. Pyrazole derivatives and pesticides
IL281212B2 (en) * 2018-09-07 2023-12-01 Merck Patent Gmbh 5-Morpholin-4-yl-pyrazolo[4,3-B]pyridine derivatives and their use
US11691971B2 (en) 2020-06-19 2023-07-04 Incyte Corporation Naphthyridinone compounds as JAK2 V617F inhibitors
WO2021257863A1 (en) 2020-06-19 2021-12-23 Incyte Corporation Pyrrolotriazine compounds as jak2 v617f inhibitors
PT4175719T (pt) 2020-07-02 2025-06-27 Incyte Corp Compostos tricíclicos de ureia como inibidores v617f de jak2
WO2022006456A1 (en) 2020-07-02 2022-01-06 Incyte Corporation Tricyclic pyridone compounds as jak2 v617f inhibitors
US11661422B2 (en) 2020-08-27 2023-05-30 Incyte Corporation Tricyclic urea compounds as JAK2 V617F inhibitors
WO2022140231A1 (en) 2020-12-21 2022-06-30 Incyte Corporation Deazaguaine compounds as jak2 v617f inhibitors
EP4298099A1 (en) 2021-02-25 2024-01-03 Incyte Corporation Spirocyclic lactams as jak2 v617f inhibitors
JP2025509672A (ja) 2022-03-17 2025-04-11 インサイト・コーポレイション Jak2 v617f阻害剤としての三環式尿素化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524146A (en) * 1982-12-08 1985-06-18 Ciba-Geigy Corporation Certain -2-heterocycle substituted pyrazoloquinolines
JPS61112075A (ja) * 1984-11-05 1986-05-30 Shionogi & Co Ltd チエニルピラゾロキノリン誘導体
SE8903564D0 (sv) * 1989-10-26 1989-10-26 Pharmacia Ab New use condensed quinoline compound
JPH05194515A (ja) * 1991-07-31 1993-08-03 Kyowa Hakko Kogyo Co Ltd 縮合ナフチリジン誘導体

Also Published As

Publication number Publication date
EP0888347A1 (en) 1999-01-07
PL328921A1 (en) 1999-03-01
IL126271A0 (en) 1999-05-09
TR199801861T2 (xx) 1998-12-21
KR20000064716A (ko) 2000-11-06
NZ331614A (en) 2000-07-28
NO984290D0 (no) 1998-09-16
AU2186797A (en) 1997-10-10
AU712141B2 (en) 1999-10-28
CN1218472A (zh) 1999-06-02
EE9800298A (et) 1999-02-15
JP2000506884A (ja) 2000-06-06
BR9708103A (pt) 1999-07-27
ID16283A (id) 1997-09-18
IS4848A (is) 1998-09-16
CA2247814A1 (en) 1997-09-25
NO984290L (no) 1998-10-27
CZ297798A3 (cs) 1999-03-17
SK118798A3 (en) 1999-03-12
WO1997034893A1 (en) 1997-09-25

Similar Documents

Publication Publication Date Title
AR006520A1 (es) Derivados de 2-arilpirazolisoquinolina y cinolinona y procedimiento para su preparacion.
ATE116295T1 (de) Perhydroisoindol derivate und ihre herstellung.
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
AR034792A1 (es) Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona, su preparacion y su aplicacion en terapeutica
SE8104941L (sv) Imidazolderivat
CY1106398T1 (el) 6,7-διυδρο-5η-πυραζολο[1,2-α]πυραζολ-1-ονες οι οποιες ελεγχουν φλεγμονωδεις κυτοκινες
AR017189A1 (es) Antagonistas del receptor de trombina triciclico sustituido, composicion farmaceutica que lo contiene y su uso para la manufactura de un medicamento
AR006793A1 (es) Compuestos pirazol o sus sales y herbicidas conteniendo los mismos
MX9305805A (es) Aroiloxicarboxamidas yodados.
DK351788A (da) Tetrahydroisoquinolin-2-ylderivater af carboxylsyrer som thromboxan-a2-antagonister
ES2083564T3 (es) Procedimiento para la preparacion de derivados de ergolina.
AR045153A1 (es) Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos
MY130817A (en) Herbicides
SE8201506L (sv) Nya fluorprostacykliner
PT916671E (pt) Novos inibidores de metaloproteases processo para a sua preparacao e as suas composicoes farmaceuticas que os contem
ES8106141A1 (es) Procedimiento de preparar derivados 3-cicloalquilsulfonilpi-rrolidina-2,5-dionicos 1-substituidos
ATE33640T1 (de) Chinolinderivate.
AR048932A1 (es) Derivados de piridoindolona substituidos en -6, su preparacion y composiciones farmaceuticas
ATE31924T1 (de) Phenethyl-1-alpha-phenyl-piperidin-3-propannitr l-derivate, ihre herstellung und therapeutische verwendung.
AU2002339174A8 (en) Light emitting device and compounds for use therein
ES8307798A1 (es) Un procedimiento para la preparacion de derivados de piperazilmetil-4-dibenzofuranona, o, dibenzofuranol.
DE69217148D1 (de) Isoxazole derivate als lichtschutzmittel
IT1221058B (it) Composti amminici come intermedi nella produzione di agenti selettivi sui ricettori istaminici e procedimenti per la produzione di detti composti amminici
DE3370627D1 (de) Acridanone derivatives
ES8206515A1 (es) Procedimiento para la preparacion de derivados de imidazol